Wolverine Trading, LLC Cara Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$0.6 - $1.65 $1,500 - $4,125	2,500 Added 11.11%	25,000 $18,000
Q3 2023 Nov 15, 2023	SELL	$1.67 - $3.33 $16,199 - $32,301	-9,700 Reduced 30.12%	22,500 $37,000
Q2 2023 Aug 23, 2023	BUY	$2.83 - $4.94 $91,126 - $159,068	32,200 New	32,200 $91,000
Q1 2022 May 16, 2022	SELL	$9.94 - $12.65 $199,794 - $254,265	-20,100 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$11.99 - $18.14 $240,999 - $364,614	20,100 New	20,100 $248,000
Q3 2021 Nov 12, 2021	SELL	$11.55 - $16.06 $286,440 - $398,287	-24,800 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$12.38 - $29.19 $110,182 - $259,791	8,900 Added 55.97%	24,800 $358,000
Q1 2021 May 14, 2021	BUY	$15.07 - $21.71 $43,703 - $62,959	2,900 Added 22.31%	15,900 $327,000
Q4 2020 Feb 12, 2021	SELL	$12.72 - $16.16 $99,216 - $126,048	-7,800 Reduced 37.5%	13,000 $200,000
Q3 2020 Nov 13, 2020	SELL	$12.34 - $17.92 $95,018 - $137,984	-7,700 Reduced 27.02%	20,800 $257,000
Q2 2020 Aug 13, 2020	BUY	$12.39 - $17.33 $19,824 - $27,727	1,600 Added 5.95%	28,500 $478,000
Q1 2020 May 11, 2020	SELL	$9.12 - $17.78 $130,415 - $254,254	-14,300 Reduced 34.71%	26,900 $357,000
Q4 2019 Feb 12, 2020	BUY	$16.11 - $25.98 $230,373 - $371,514	14,300 Added 53.16%	41,200 $676,000
Q3 2019 Nov 14, 2019	SELL	$18.28 - $26.91 $378,396 - $557,037	-20,700 Reduced 43.49%	26,900 $501,000
Q2 2019 Aug 20, 2019	SELL	$17.68 - $21.57 $350,064 - $427,086	-19,800 Reduced 29.38%	47,600 $1.02 Million
Q1 2019 May 15, 2019	BUY	$14.41 - $19.64 $265,144 - $361,376	18,400 Added 37.55%	67,400 $1.32 Million
Q4 2018 Feb 14, 2019	SELL	$12.45 - $23.47 $336,150 - $633,690	-27,000 Reduced 35.53%	49,000 $622,000
Q3 2018 Nov 14, 2018	BUY	$17.57 - $23.95 $586,838 - $799,930	33,400 Added 78.4%	76,000 $1.82 Million
Q1 2018 May 15, 2018	BUY	$11.77 - $16.08 $501,402 - $685,007	42,600 New	42,600 $527,000

Others Institutions Holding CARA

# of Institutions

Shares Held

12.8M

Call Options Held

Put Options Held

Vanguard Group Inc Valley Forge, PA

2.25M
Shares

$11.6 Million
0.0% of portfolio
Chescapmanager LLC Baltimore, MD

1.7M
Shares

$8.8 Million
0.06% of portfolio
Farallon Capital Management LLC San Francisco, CA

1.56M
Shares

$8.05 Million
0.0% of portfolio
Disciplined Growth Investors Inc Minneapolis, MN

1.11M
Shares

$5.75 Million
0.01% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.11M
Shares

$5.73 Million
0.0% of portfolio

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $278M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account